Samsung Medical Center
1,180
135
173
554
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.5%
53 terminated/withdrawn out of 1180 trials
91.3%
+4.7% vs industry average
14%
165 trials in Phase 3/4
4%
21 of 554 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1180)
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
Role: lead
A Korean Point Prevalence Study of Acute Rehabilitation for Kids in the PICU (PARK-PICU)
Role: lead
Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable Criterion Defining GMFCS Levels in Children Aged 2 to 6 Years With Cerebral Palsy
Role: lead
Opiranserin Injections PCA Regimens for Postoperative Pain
Role: lead
Effect of Individualized Positive End-expiratory Pressure (PEEP) in Patients Who Have an Intrinsic PEEP During One-lung Ventilation
Role: lead
Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy
Role: lead
Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission
Role: lead
3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device
Role: lead
Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation
Role: lead
Comparing the Effectiveness of Large Language Model-Based and Video-Based Refresher Education on Knowledge Retention After Simulation-Based Pediatric Cardiopulmonary Resuscitation Training: A Six-Month Follow-Up Study
Role: lead
Thoracoscopic Versus Catheter Ablation in Persistent Atrial Fibrillation With Enlarged Left Atrium
Role: lead
Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
Role: lead
Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Role: lead
Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring
Role: collaborator
A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy
Role: lead
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
Role: lead
Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
Role: lead
Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer
Role: lead
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Role: lead
SMC Radiation Oncology Breast Cancer Cohort Study
Role: lead